Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Receptor Mutations
| Autor: | Farina, Gabriella, Longo, Flavia, Martelli, Olga, Pavese, Ida, Mancuso, Andrea, Moscetti, Luca, Labianca, Roberto, Bertolini, Alessandro, Cortesi, Enrico, Farris, Antonio, Fagnani, Daniele, Locatelli, Maria Cristina, Valmadre, Giuseppe, Ardizzoia, Antonio, Tomirotti, Maurizio, Rulli, Eliana, Garassino, Marina Chiara, Scanni, Alberto |
|---|---|
| Zdroj: | In Clinical Lung Cancer March 2011 12(2):138-141 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect